Previous close | 1.1500 |
Open | 1.2800 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 1.1500 - 1.3700 |
52-week range | 0.3200 - 1.4900 |
Volume | |
Avg. volume | 11,977 |
Market cap | 75.147M |
Beta (5Y monthly) | 1.49 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0600 |
Earnings date | 24 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 1.50 |
Nanophase Technologies Corporation (PNK:NANX) Q1 2024 Earnings Call Transcript April 24, 2024 Nanophase Technologies Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by, and welcome to today’s program entitled Nanophase’s First Quarter 2024 Financial Conference […]
— Delivered $9.9 Million in Q1 Revenue— $0.9 Million in Profit— BASF Litigation Resolved ROMEOVILLE, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced financial results for the first quarter ended March 31, 2024. Jess Jankowski
Romeoville, Ill., April 19, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced the Company will disseminate a financial news release for the First Quarter 2024 after market close on Tuesday, April 23, 2024, with an investor conference call to f